Unknown

Dataset Information

0

Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis.


ABSTRACT: Two new rifabutin analogs, RFA-1 and RFA-2, show high in vitro antimycobacterial activities against Mycobacterium tuberculosis. MIC values of RFA-1 and RFA-2 were ?0.02 ?g/ml against rifamycin-susceptible strains and 0.5 ?g/ml against a wide selection of multidrug-resistant strains, compared to ?50 ?g/ml for rifampin and 10 ?g/ml for rifabutin. Molecular dynamic studies indicate that the compounds may exert tighter binding to mutants of RNA polymerase that have adapted to the rifamycins.

SUBMITTER: Garcia AB 

PROVIDER: S-EPMC2981290 | biostudies-literature | 2010 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis.

García Ana-Belén AB   Palacios Juan J JJ   Ruiz María-Jesús MJ   Barluenga José J   Aznar Fernando F   Cabal María-Paz MP   García José María JM   Díaz Natalia N  

Antimicrobial agents and chemotherapy 20100920 12


Two new rifabutin analogs, RFA-1 and RFA-2, show high in vitro antimycobacterial activities against Mycobacterium tuberculosis. MIC values of RFA-1 and RFA-2 were ≤0.02 μg/ml against rifamycin-susceptible strains and 0.5 μg/ml against a wide selection of multidrug-resistant strains, compared to ≥50 μg/ml for rifampin and 10 μg/ml for rifabutin. Molecular dynamic studies indicate that the compounds may exert tighter binding to mutants of RNA polymerase that have adapted to the rifamycins. ...[more]

Similar Datasets

| S-EPMC4249568 | biostudies-literature
| S-EPMC4704149 | biostudies-literature
| S-EPMC5740303 | biostudies-literature
| S-EPMC3110937 | biostudies-literature
| S-EPMC7848999 | biostudies-literature
| S-EPMC9769715 | biostudies-literature
| S-EPMC8635133 | biostudies-literature
| S-EPMC4068502 | biostudies-literature
| S-EPMC4412083 | biostudies-other
| S-EPMC16924 | biostudies-literature